VJOncology is committed to improving our service to you

ESMO 2019 | Who are the long-term responders to immuno and targeted therapy in melanoma?

VJOncology is committed to improving our service to you

Paolo Ascierto

Paolo Ascierto, MD, National Tumor Institute, Milan, Italy, discusses who the long-term responders are to immunotherapy and targted therapy in melanoma. This interview took place at the European Society for Medical Oncology (ESMO) 2019 congress in Barcelona, Spain.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter